The Pharmaceutical Intellectual Property and Competition Law Review
Written By
Partner
UK
As one of our firm's most experienced intellectual property partners, specialising in transactional IP matters, I offer a wealth of knowledge to businesses at the cutting edge of research, development and technology, in a variety of sectors for which IP is of prime importance.
Partner
UK
A partner in our Competition & EU Law practice group based in London, I bring over 25 years' experience of providing solutions for our clients in highly regulated and technically complex markets.
Senior Associate
UK
I am a senior associate in the Intellectual Property Group in London, with a focus on regulatory and commercial matters primarily in the life sciences and healthcare sectors.
Related
Practices
Sectors
Regions
Countries
Offices
The Pharmaceutical Intellectual Property and Competition Law Review provides a practical overview of pharmaceutical intellectual property issues, including patent linkage and exclusivities, and related competition concerns. With a focus on recent developments, it is a useful tool for managing global risks in this area – analysing the key elements of the relevant legal and regulatory regimes across major jurisdictions worldwide.
Read the full chapter here
Latest insights
More Insights
UAE announces initiatives to enhance intellectual property protection for circular economy technologies and broader patent registrations
2 minutes Mar 28 2025
English Court of Appeal uphold decision declaring that MSD had used “Merck” in breach of Court Order
3 minutes Mar 28 2025
Key Takeaways from EU Foreign Subsidies Regulation Webinar: Cutting-Edge Cases and Insights
5 minutes Mar 27 2025